
Christine J. Saoud
Examiner (ID: 16605, Phone: (571)272-0891 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1645, 1812, 2899, 1616, 1647, 1646, 1801 |
| Total Applications | 1551 |
| Issued Applications | 753 |
| Pending Applications | 184 |
| Abandoned Applications | 635 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7691241
[patent_doc_number] => 20070232792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Method for the Production of Recombinant Peptides with a Low Amount of Trisulfides'
[patent_app_type] => utility
[patent_app_number] => 11/750692
[patent_app_country] => US
[patent_app_date] => 2007-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2123
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232792.pdf
[firstpage_image] =>[orig_patent_app_number] => 11750692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/750692 | Method for the Production of Recombinant Peptides with a Low Amount of Trisulfides | May 17, 2007 | Abandoned |
Array
(
[id] => 5465672
[patent_doc_number] => 20090325872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'USE OF ALPHA-LACTALBUMIN FOR REGULATIONS OF GLYCEMIA'
[patent_app_type] => utility
[patent_app_number] => 12/298417
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5824
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325872.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298417
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298417 | Use of alpha-lactalbumin for regulations of glycemia | Apr 23, 2007 | Issued |
Array
(
[id] => 5465660
[patent_doc_number] => 20090325860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'COMPOSITIONS FOR INTRANASAL DELIVERY OF HUMAN INSULIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/376205
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 43035
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325860.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376205
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376205 | COMPOSITIONS FOR INTRANASAL DELIVERY OF HUMAN INSULIN AND USES THEREOF | Apr 18, 2007 | Abandoned |
Array
(
[id] => 162885
[patent_doc_number] => 07671180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Fibroblast growth factor-like polypeptides and variants thereof'
[patent_app_type] => utility
[patent_app_number] => 11/733769
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30292
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/671/07671180.pdf
[firstpage_image] =>[orig_patent_app_number] => 11733769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/733769 | Fibroblast growth factor-like polypeptides and variants thereof | Apr 10, 2007 | Issued |
Array
(
[id] => 168859
[patent_doc_number] => 07667008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Fibroblast growth factor-like polypeptides and variants thereof'
[patent_app_type] => utility
[patent_app_number] => 11/733771
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30292
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/667/07667008.pdf
[firstpage_image] =>[orig_patent_app_number] => 11733771
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/733771 | Fibroblast growth factor-like polypeptides and variants thereof | Apr 10, 2007 | Issued |
Array
(
[id] => 6636206
[patent_doc_number] => 20100035804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'POLYPEPTIDE ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/296180
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7277
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035804.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296180 | POLYPEPTIDE ANTAGONIST | Apr 4, 2007 | Abandoned |
Array
(
[id] => 4909153
[patent_doc_number] => 20080019919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium'
[patent_app_type] => utility
[patent_app_number] => 11/728075
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4727
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20080019919.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728075
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728075 | Method for optimizing cancer therapy by monitoring maturation of tumor associated vasculature by selenium | Mar 22, 2007 | Issued |
Array
(
[id] => 5285390
[patent_doc_number] => 20090099065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Acylated Single Chain Insulin'
[patent_app_type] => utility
[patent_app_number] => 12/282788
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13656
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099065.pdf
[firstpage_image] =>[orig_patent_app_number] => 12282788
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/282788 | Acylated Single Chain Insulin | Mar 11, 2007 | Abandoned |
Array
(
[id] => 5453178
[patent_doc_number] => 20090069215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Acylated Single Chain Insulin'
[patent_app_type] => utility
[patent_app_number] => 12/282787
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13402
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12282787
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/282787 | Acylated Single Chain Insulin | Mar 11, 2007 | Abandoned |
Array
(
[id] => 5453179
[patent_doc_number] => 20090069216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/280183
[patent_app_country] => US
[patent_app_date] => 2007-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10112
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069216.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280183
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280183 | Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof | Feb 18, 2007 | Abandoned |
Array
(
[id] => 8642625
[patent_doc_number] => 08367609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Methods of reducing skin damage and edema'
[patent_app_type] => utility
[patent_app_number] => 11/654776
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16487
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11654776
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654776 | Methods of reducing skin damage and edema | Jan 17, 2007 | Issued |
Array
(
[id] => 5552979
[patent_doc_number] => 20090286965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'MUTANT GROWTH FACTORS WITH ALTERED RECEPTOR SPECIFICITIES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/159854
[patent_app_country] => US
[patent_app_date] => 2007-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8603
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286965.pdf
[firstpage_image] =>[orig_patent_app_number] => 12159854
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/159854 | Isolated mutant protein of fibroblast growth factor 18 and pharmaceutical composition comprising the same | Jan 8, 2007 | Issued |
Array
(
[id] => 5367255
[patent_doc_number] => 20090304814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'FIBRILLATION RESISTANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/160187
[patent_app_country] => US
[patent_app_date] => 2007-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6049
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304814.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160187 | Fibrillation resistant proteins | Jan 7, 2007 | Issued |
Array
(
[id] => 4983592
[patent_doc_number] => 20070088151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/642816
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38604
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088151.pdf
[firstpage_image] =>[orig_patent_app_number] => 11642816
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/642816 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 18, 2006 | Abandoned |
Array
(
[id] => 5135997
[patent_doc_number] => 20070077626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'POLYPEPTIDES SHARING SEQUENCE IDENTITY WITH A FIBROBLAST GROWTH FACTOR POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/611037
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 38335
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077626.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611037 | POLYPEPTIDES SHARING SEQUENCE IDENTITY WITH A FIBROBLAST GROWTH FACTOR POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5236030
[patent_doc_number] => 20070128186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Proliferative glomerulonephritis-related gene'
[patent_app_type] => utility
[patent_app_number] => 11/606133
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32596
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128186.pdf
[firstpage_image] =>[orig_patent_app_number] => 11606133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/606133 | Proliferative glomerulonephritis-related gene | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5343238
[patent_doc_number] => 20090181888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/085221
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8237
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181888.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085221 | Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5368410
[patent_doc_number] => 20090305969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/085220
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7356
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085220 | Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5253888
[patent_doc_number] => 20070135344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Novel growth factor and a genetic sequence encoding same'
[patent_app_type] => utility
[patent_app_number] => 11/602055
[patent_app_country] => US
[patent_app_date] => 2006-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 9373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11602055
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/602055 | Novel growth factor and a genetic sequence encoding same | Nov 19, 2006 | Abandoned |
Array
(
[id] => 4970733
[patent_doc_number] => 20070110735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Methods for regulating angiogenesis and vascular integrity using trk receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/589659
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14199
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110735.pdf
[firstpage_image] =>[orig_patent_app_number] => 11589659
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/589659 | Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands | Oct 29, 2006 | Issued |